ZLAB logo

ZLAB
Zai Lab Ltd

1,232
Mkt Cap
$2.29B
Volume
1,250.00
52W High
$44.34
52W Low
$15.96
PE Ratio
-12.65
ZLAB Fundamentals
Price
$20.34
Prev Close
$18.81
Open
$19.89
50D MA
$18.56
Beta
1.14
Avg. Volume
748,142.65
EPS (Annual)
-$1.61
P/B
3.15
Rev/Employee
$258,617.15
$1,366.81
Loading...
Loading...
News
all
press releases
Zai Lab (NASDAQ:ZLAB) Trading 9.5% Higher - Still a Buy?
Zai Lab (NASDAQ:ZLAB) Trading Up 9.5% - What's Next...
MarketBeat·18h ago
News Placeholder
More News
News Placeholder
Zai Lab Stock Gains 8% Over Clinical Trial Collaboration With Amgen
(RTTNews) - Shares of Zai Lab Limited (ZLAB) are moving up about 8 percent on Wednesday morning trading after the company announced a global clinical trial collaboration with Amgen Inc. (AMGN) to...
Nasdaq News: Markets·21h ago
News Placeholder
Zai Lab Announces Global Clinical Trial Collaboration and Supply Agreement to Evaluate Novel DLL3 ADC, Zocilurtatug Pelitecan, in Combination with a Bispecific T-cell Engager Therapy
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced a global clinical trial collaboration with Amgen Inc. (NASDAQ: AMGN) to evaluate Zai Labs investigational delta-like ligand 3...
Business Wire·24h ago
News Placeholder
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Sees Large Growth in Short Interest
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB - Get Free Report) saw a large increase in short interest in the month of March. As of March 13th, there was short interest totaling 4,890,948 shares, an increase of 28.7% from the February 26th total of 3,800,411 shares. Based on an average daily...
MarketBeat·3d ago
News Placeholder
Zai Lab (NASDAQ:ZLAB) Director Buys $32,733.21 in Stock
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB - Get Free Report) Director Richard Gaynor bought 1,731 shares of Zai Lab stock in a transaction dated Tuesday, March 17th. The shares were bought at an average cost of $18.91 per share, for a total transaction of $32,733.21. Following the completion of...
MarketBeat·13d ago
News Placeholder
Richard Gaynor Acquires 1,731 Shares of Zai Lab (NASDAQ:ZLAB) Stock
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB - Get Free Report) Director Richard Gaynor acquired 1,731 shares of the business's stock in a transaction that occurred on Tuesday, March 17th. The shares were purchased at an average price of $18.91 per share, with a total value of $32,733.21. Following...
MarketBeat·14d ago
News Placeholder
Zai Lab (NASDAQ:ZLAB) Given New $32.00 Price Target at JPMorgan Chase & Co.
JPMorgan Chase & Co. cut their price target on shares of Zai Lab from $39.00 to $32.00 and set an "overweight" rating for the company in a research note on Wednesday...
MarketBeat·15d ago
News Placeholder
Zai Lab to Present New Data on Three Internally Developed Oncology Candidates at AACR 2026, Including Zocilurtatug Pelitecan, a DLL3-Targeting Antibody-Drug Conjugate (ADC)
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced three of the Companys internally-developed investigational oncology therapies will be presented across four poster sessions at the upcoming...
Business Wire·16d ago
News Placeholder
Zai Lab (NASDAQ:ZLAB) Insider Rafael Amado Sells 2,957 Shares
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB - Get Free Report) insider Rafael Amado sold 2,957 shares of the stock in a transaction dated Friday, March 13th. The stock was sold at an average price...
MarketBeat·16d ago
News Placeholder
Zai Lab (NASDAQ:ZLAB) CFO Sells $31,726.89 in Stock
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB - Get Free Report) CFO Yajing Chen sold 1,703 shares of Zai Lab stock in a transaction dated Friday, March 13th. The stock was sold at an average price of...
MarketBeat·17d ago
<
1
2
...
>

Latest ZLAB News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.